136 related articles for article (PubMed ID: 2306733)
1. Detection of pS2 messenger RNA in gynecological cancers.
Wysocki SJ; Hahnel E; Masters A; Smith V; McCartney AJ; Hahnel R
Cancer Res; 1990 Mar; 50(6):1800-2. PubMed ID: 2306733
[TBL] [Abstract][Full Text] [Related]
2. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer.
Rio MC; Chambon P
Cancer Cells; 1990; 2(8-9):269-74. PubMed ID: 2223388
[TBL] [Abstract][Full Text] [Related]
3. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.
Daffada AA; Johnston SR; Smith IE; Detre S; King N; Dowsett M
Cancer Res; 1995 Jan; 55(2):288-93. PubMed ID: 7812959
[TBL] [Abstract][Full Text] [Related]
4. Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts.
Dante R; Ribieras S; Baldassini S; Martin V; Benzerara O; Bouteille C; Brémond A; Frappart L; Rio MC; Lasne Y
Lab Invest; 1994 Aug; 71(2):188-92. PubMed ID: 8078298
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptors.
Saegusa M; Hashimura M; Hara A; Okayasu I
J Pathol; 2000 Apr; 190(5):554-63. PubMed ID: 10727981
[TBL] [Abstract][Full Text] [Related]
6. Hormone-regulated genes (pS2, PIP, FAS) in breast cancer and nontumoral mammary tissue.
Hähnel E; Harvey J; Robbins P; Sterrett G; Hähnel R
Pathobiology; 1994; 62(2):82-9. PubMed ID: 7945916
[TBL] [Abstract][Full Text] [Related]
7. pS2 and PAI-1 in ovarian cancer: correlation to pathohistological parameters.
Speiser P; Mayerhofer K; Kucera E; Roch G; Mittelböck M; Gitsch G; Zeillinger R
Anticancer Res; 1997; 17(1B):679-83. PubMed ID: 9066601
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of prognostic significance of the estrogen-inducible pS2 gene in male breast carcinoma.
Kardaś I; Seitz G; Limon J; Niezabitowski A; Ryś J; Theisinger B; Welter C; Blin N
Cancer; 1993 Sep; 72(5):1652-6. PubMed ID: 8394203
[TBL] [Abstract][Full Text] [Related]
9. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of pS2 mRNA in breast cancer.
Wysocki SJ; Iacopetta BJ; Ingram DM
Eur J Cancer; 1994; 30A(12):1882-4. PubMed ID: 7880621
[TBL] [Abstract][Full Text] [Related]
11. Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer.
Hähnel E; Joyce R; Sterrett G; Harvey J; Hähnel R
Breast Cancer Res Treat; 1992 Mar; 20(3):167-76. PubMed ID: 1571569
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer-associated protein pS2 expression in tumors of the biliary tract.
Seitz G; Thelsinger B; Tomasetto G; Rio MC; Chambon P; Blin N; Welter G
Am J Gastroenterol; 1991 Oct; 86(10):1491-4. PubMed ID: 1928043
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells.
Cavailles V; Garcia M; Rochefort H
Mol Endocrinol; 1989 Mar; 3(3):552-8. PubMed ID: 2664475
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers.
Delvenne CG; Winkler-Gol RA; Piccart MJ; Hustin J; Michaux D; Leclercq G; Nogaret JM; Autier P
Eur J Cancer; 1992; 28(2-3):700-5. PubMed ID: 1350458
[TBL] [Abstract][Full Text] [Related]
15. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer.
Zaretsky JZ; Weiss M; Tsarfaty I; Hareuveni M; Wreschner DH; Keydar I
FEBS Lett; 1990 Jun; 265(1-2):46-50. PubMed ID: 2194831
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
Neri C; Colomb E; Roux-Dosseto M; Martin PM
Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
[TBL] [Abstract][Full Text] [Related]
17. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma.
Welter C; Theisinger B; Seitz G; Tomasetto C; Rio MC; Chambon P; Blin N
Lab Invest; 1992 Feb; 66(2):187-92. PubMed ID: 1735955
[TBL] [Abstract][Full Text] [Related]
18. [Specific expression of human pS2 gene in breast cancer].
Rio MC; Bellocq JP; Gairard B; Koehl C; Renaud R; Chambon P
Biochimie; 1988 Jul; 70(7):961-8. PubMed ID: 3145028
[TBL] [Abstract][Full Text] [Related]
19. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma.
Takahashi H; Kida N; Fujii R; Tanaka K; Ohta M; Mori K; Hayashi K
FEBS Lett; 1990 Feb; 261(2):283-6. PubMed ID: 2311759
[TBL] [Abstract][Full Text] [Related]
20. Correlation of cytosolic concentrations of ER, PS2, Cath-D, TPS, TK and cAMP in primary breast carcinomas.
Kausitz J; Kuliffay P; Pecen L; Eben K; Puterová B
Neoplasma; 1994; 41(6):331-6. PubMed ID: 7870216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
